Adriano D. Andricopulo
BR 465, Km 07, 23.890-000
Seropedica, RJ, Brazil
Seropedica, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 129 publications
Identification of a Benzenesulfonylpiperazine Derivative With In Vivo Efficacy Against Visceral Leishmaniasis.
Journal: Chemical biology & drug design
Published: April 10, 2026
Multiscale-Aware Graph Embedding Approach Uncovers LC-61, a Potent Anti-Leishmania infantum Compound.
Journal: Journal of chemical information and modeling
Published: March 17, 2026
Discovery of an efficacious 2-ethyl-4-phenylthiazole derivative against acute Chagas disease via multiparametric hit-to-lead optimization and in vivo efficacy.
Journal: European journal of medicinal chemistry
Published: March 09, 2026
Hit-To-Lead Optimization of a Pyridylpiperazine Class Against Malaria: Pharmacokinetic Profile and In Vivo Efficacy of Optimized Compounds.
Journal: ChemMedChem
Published: January 31, 2026
Cinnamoyl aryl hydrazones as potent leishmanicidal agents: design, synthesis, and structure-activity relationships.
Journal: Bioorganic & medicinal chemistry letters
Published: October 06, 2025
In Silico Studies and Biological Evaluation of Thiosemicarbazones as Cruzain-Targeting Trypanocidal Agents for Chagas Disease.
Journal: Pharmaceutics
Published: August 25, 2025
Exploring the bioactivity potential of fruit-associated fungi: Antifungal, antiparasitic, and antiviral activities of natural extracts.
Journal: Fitoterapia
Published: July 21, 2025
Design and Synthesis of Boronic Chalcones with Dual Anticancer and Anti-Inflammatory Activity.
Journal: Molecules (Basel, Switzerland)
Published: June 11, 2025
Phenotypic Screening of H1-Antihistamines Identifies Promethazine and Rupatadine as Active Compounds Against Toxocara canis Infective Larvae.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 10, 2025
Design, Synthesis, and In Vitro Evaluation of 4-(Arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: Exploring Their Potential Against Tuberculosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 01, 2025
Hit-to-Lead Studies of Pyrazinylpiperazines against Visceral Leishmaniasis: Pharmacokinetic Profile and In Vivo Efficacy of Potent Compounds against Leishmania infantum.
Journal: ACS pharmacology & translational science
Published: April 29, 2025
Co-cultivation and Medium Optimization: A Strategy for Discovering Fungal-derived Protease Inhibitors.
Journal: Chemistry & biodiversity
Published: April 01, 2025
Last Updated: 09/26/2026